Capital Impact Advisors, LLC Penumbra Inc Transaction History

Capital Impact Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$185.27 - $238.73 $1.64 Million - $2.12 Million	-8,873 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$153.32 - $191.72 $806,923 - $1.01 Million	-5,263 Reduced 37.23%	8,873 $1.59 Million
Q1 2020 May 15, 2020	BUY	$124.34 - $193.76 $57,569 - $89,710	463 Added 3.39%	14,136 $2.28 Million
Q4 2019 Feb 13, 2020	BUY	$134.81 - $177.8 $117,823 - $155,397	874 Added 6.83%	13,673 $2.25 Million
Q3 2019 Nov 14, 2019	BUY	$131.82 - $183.4 $336,404 - $468,036	2,552 Added 24.9%	12,799 $1.69 Million
Q2 2019 Jul 19, 2019	BUY	$124.65 - $167.39 $1.28 Million - $1.72 Million	10,247 New	10,247 $1.64 Million

370

29.1M

220K

158K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.